Author

Romano A

Oasi Research Institute-IRCCS, Troina, Italy; Fondazione Mediterranea G.B. Morgagni, Catania, Italy - Cited by 27,454 - Allergology - Medicine

Biography

Dr.  Romano A is currently working in Division of Hematology, Azienda Policlinico-Vittorio Emanuele-Catania, Italy. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
IJ Ansotegui, G Melioli, GW Canonica, L Caraballo, E Villa, M Ebisawa, ...World allergy organization journal 13 (2), 100080, 2020202
278
2020
Towards a more precise diagnosis of hypersensitivity to beta‐lactams—an EAACI position paper
A Romano, M Atanaskovic‐Markovic, A Barbaud, AJ Bircher, K Brockow, ...Allergy 75 (6), 1300-1315, 2020202
203
2020
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.
ZT Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, Ansotegui IJ ...Allergy, 2020202
185
2020
Is Diet Partly Responsible for Differences in COVID-19 Death Rates Between and Within Countries?
Clinical Translational Allergy 10 (May), 16, 2020202
145
2020
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
ZT Klimek L, Jutel M, Akdis C, Bousquet J, Akdis M, Bachert C, Agache I ...Allergy, 2020202
129
2020
Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs
AD Broyles, A Banerji, S Barmettler, CM Biggs, K Blumenthal, PJ Brennan, ...The Journal of Allergy and Clinical Immunology: In Practice 8 (9), S16-S, 2020202
116
2020
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ...Allergy 76 (3), 735-750, 2021202
106
2021
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
MC Fargnoli, M Esposito, S Ferrucci, G Girolomoni, A Offidani, A Patrizi, ...Journal of Dermatological Treatment 32 (5), 507-513, 2021202
62
2021
Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies
J Bousquet, JP Cristol, W Czarlewski, JM Anto, A Martineau, T Haahtela, ...Clinical and translational allergy 10 (1), 58, 2020202
57
2020
ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice
J Bousquet, JM Anto, C Bachert, T Haahtela, T Zuberbier, W Czarlewski, ...Allergy 76 (1), 168-190, 2021202
55
2021
Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper
A Barbaud, LH Garvey, A Arcolaci, K Brockow, F Mori, C Mayorga, ...Allergy 77 (8), 2292-2312, 2022202
52
2022
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
J Hagemann, GL Onorato, M Jutel, CA Akdis, I Agache, T Zuberbier, ...Allergy 76 (8), 2354-2366, 2021202
39
2021
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air® App
A Bédard, JM Antó, JA Fonseca, S Arnavielhe, C Bachert, A Bedbrook, ...Allergy 75 (7), 1672-1688, 2020202
35
2020
Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort
P Nicoletti, DF Carr, S Barrett, L Mcevoy, PS Friedmann, NH Shear, ...Journal of Allergy and Clinical Immunology 147 (5), 18-1837. e15, 2021202
30
2021
Tolerability of cefazolin and ceftibuten in patients with IgE-mediated aminopenicillin allergy
A Romano, RL Valluzzi, C Caruso, A Zaffiro, D Quaratino, F GaetaThe Journal of Allergy and Clinical Immunology: In Practice 8 (6), 1989-1993. e2, 2020202
29
2020
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: an EAACI Position Paper
A Gelincik, K Brockow, GE Çelik, I Doña, C Mayorga, A Romano, Ö Soyer, ...Allergy 75 (11), 2775-2793, 2020202
26
2020
β-lactam allergy and cross-reactivity: a clinician’s guide to selecting an alternative antibiotic
C Caruso, RL Valluzzi, S Colantuono, F Gaeta, A RomanoJournal of asthma and allergy, 31-46, 2021202
22
2021
Urticaria: the 1-1-1 criterion for optimized risk stratification in β-Lactam allergy delabeling
V Sabato, F Gaeta, RL Valluzzi, A Van Gasse, DG Ebo, A RomanoThe Journal of Allergy and Clinical Immunology: In Practice 9 (10), 3697-3704, 202
21
2021
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement
E Alvarez-Cuesta, R Madrigal-Burgaleta, AD Broyles, J Cuesta-Herranz, ...World Allergy Organization Journal 15 (6), 100640, 2022202
16
2022
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
J Bousquet, I Agache, H Blain, M Jutel, MT Ventura, M Worm, ...Allergy 76 (10), 2952-2964, 2021202
15
2021

Referred From: https://scholar.google.com/citations?hl=en&user=_--iafQAAAAJ

Cited by
Citations 27454
h-index 87
i10-index 258
Recommended Journals
Open Access Journals